GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pacific Biosciences of California Inc (STU:P09) » Definitions » Net Margin %

Pacific Biosciences of California (STU:P09) Net Margin % : -151.94% (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Pacific Biosciences of California Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Pacific Biosciences of California's Net Income for the three months ended in Sep. 2024 was €-54.7 Mil. Pacific Biosciences of California's Revenue for the three months ended in Sep. 2024 was €36.0 Mil. Therefore, Pacific Biosciences of California's net margin for the quarter that ended in Sep. 2024 was -151.94%.

The historical rank and industry rank for Pacific Biosciences of California's Net Margin % or its related term are showing as below:

STU:P09' s Net Margin % Range Over the Past 10 Years
Min: -244.92   Med: -103.91   Max: 37.27
Current: -227.69


STU:P09's Net Margin % is ranked worse than
84.41% of 821 companies
in the Medical Devices & Instruments industry
Industry Median: -1.28 vs STU:P09: -227.69

Pacific Biosciences of California Net Margin % Historical Data

The historical data trend for Pacific Biosciences of California's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pacific Biosciences of California Net Margin % Chart

Pacific Biosciences of California Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -92.57 37.27 -138.85 -244.92 -152.97

Pacific Biosciences of California Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -120.07 -140.55 -201.44 -481.27 -151.94

Competitive Comparison of Pacific Biosciences of California's Net Margin %

For the Medical Devices subindustry, Pacific Biosciences of California's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pacific Biosciences of California's Net Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pacific Biosciences of California's Net Margin % distribution charts can be found below:

* The bar in red indicates where Pacific Biosciences of California's Net Margin % falls into.



Pacific Biosciences of California Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Pacific Biosciences of California's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-281.276/183.878
=-152.97 %

Pacific Biosciences of California's Net Margin for the quarter that ended in Sep. 2024 is calculated as

Net Margin=Net Income (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=-54.713/36.01
=-151.94 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pacific Biosciences of California  (STU:P09) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Pacific Biosciences of California Net Margin % Related Terms

Thank you for viewing the detailed overview of Pacific Biosciences of California's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pacific Biosciences of California Business Description

Traded in Other Exchanges
Address
1305 O’Brien Drive, Menlo Park, CA, USA, 94025
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

Pacific Biosciences of California Headlines

No Headlines